|
Consolidated Statements of Stockholders Equity (Deficit) (USD $)
|
Series E Preferred stock
USD ($)
|
Series F Preferred stock
USD ($)
|
Series G Preferred stock
|
Series H Preferred stock
|
Series I Preferred stock
USD ($)
|
Series J Preferred stock
|
Common Stock Shares
USD ($)
|
Common Stock Amount
USD ($)
|
Additional Paid-In Capital
USD ($)
|
Accumulated Deficit
USD ($)
|
Non-Controlling Interest in Subsidiary
USD ($)
|
Total Stockholders' Equity (Deficit)
USD ($)
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at Jun. 30, 2011 | 300,000 | 0 | 0 | 0 | 0 | 0 | 481,117 | 481 | 3,037,750 | (187,291) | (286,190) | |
| Sale of Common stock | 4,191 | 4 | 34,635 | 34,640 | ||||||||
| Deferred stock issuance costs | $ (36,000) | $ (36,000) | ||||||||||
| Warrants issued with convertible notes payable | 49,005 | 49,005 | ||||||||||
| Restricted stock award | 29,167 | 29,167 | ||||||||||
| Conversion of 100 shares of preferred stock- Series E to common stock | (100,000) | 9,006 | 9 | 99,991 | ||||||||
| Cash dividends accrued on preferred stock - Series E | (13,360) | (13,360) | ||||||||||
| Stock based Compensation | 494,989 | 494,989 | ||||||||||
| Net loss | (2,056,310) | 2,689 | (2,053,621) | |||||||||
| Balance at Jun. 30, 2012 | 200,000 | 494,313 | 494 | 3,696,178 | (5,493,440) | (184,602) | (1,781,370) | |||||
| Sale of Common stock | 2,807 | 3 | 5,997 | 6,000 | ||||||||
| Sale of 90 shares of Series F Preferred Stock | 90,000 | 90,000 | ||||||||||
| Warrants issued for Convertible notes payable | 5,410 | 5,410 | ||||||||||
| Beneficial conversion feature on notes payable | 133,222 | 133,222 | ||||||||||
| Restricted stock award | 10,000 | 10 | 20,823 | 20,823 | ||||||||
| Conversion of notes payable to common stock | 947,238 | 947 | 288,973 | 289,920 | ||||||||
| Rescission of common shares issued at par | (12,818) | (13) | 13 | |||||||||
| Conversion of 100 shares of Series E Preferred Stock to note payable | (100,000) | (100,000) | ||||||||||
| Cash dividends accrued on Series E Preferred stock | (5,617) | (5,617) | ||||||||||
| Issuance of Series H Preferred stock | 60,000 | 60,000 | ||||||||||
| Stock-based compensation | 526,113 | 526,113 | ||||||||||
| Net loss | (1,976,692) | (17,475) | (1,994,167) | |||||||||
| Balance at Jun. 30, 2013 | 100,000 | 90,000 | 1,441,540 | 1,442 | 4,731,112 | (7,470,132) | (202,077) | (2,749,656) | ||||
| Cash dividends accrued on Series E Preferred stock | (1,139) | (1,139) | ||||||||||
| Shares issued for debt converted in prior quarter | 15,043,524 | 15,044 | 1,747,581 | 1,762,624 | ||||||||
| Beneficial conversion feature on notes payable | 497,500 | 497,500 | ||||||||||
| Conversion of 100 shares of Series E Preferred Stock to note payable | (100,000) | (100,000) | ||||||||||
| Issuance of Series I Preferred stock | 4 | 1,039,070 | 1,039,074 | |||||||||
| Stock-based compensation | 433,190 | 433,190 | ||||||||||
| Net loss | (2,508,950) | (2,508,950) | ||||||||||
| Balance at Jun. 30, 2014 | 90,000 | 4 | 16,485,064 | 16,485 | 8,447,315 | (9,979,082) | (202,077) | (1,627,356) | ||||
| Shares issued for conversion of debt | 9,606,378 | 9,606 | 226,108 | 235,714 | ||||||||
| Fractional shares issued for reverse split | 3,763 | 4 | 4 | |||||||||
| Write-down of Investment in Unconsolidated subsidiary | (1,039,074) | (1,039,074) | ||||||||||
| Net loss | $ (545,686) | $ (545,686) | ||||||||||
| Balance at Sep. 30, 2014 | 90,000 | 4 | 26,095,205 | 26,095 | 7,634,348 | (10,524,768) | (202,077) | (2,976,398) |